Submitted:
17 November 2026
Posted:
18 November 2026
You are already at the latest version
Abstract
Background: We reviewed the photodynamic antimicrobial activity of plant-derived photosensitizers and their derivatives, with a focus on documented Brazilian provenance, bacterial resistance prioritized by the World Health Organization, and prospects for pharmaceutical development. Methods: A systematic review registered in PROSPERO (CRD420261385328), with searches in PubMed/MEDLINE, Embase, Scopus, and LILACS for publications from 2015–2026. Reporting followed PRISMA 2020/PRISMA-S, and the narrative synthesis followed SWiM. Methodological assessment used SYRCLE, JBI, and an adapted matrix. Results: Of the 174 records identified, 98 remained after deduplication; 62 reports were included, corresponding to 61 document families and 469 data-extraction conditions. The main evidence comprised six conditions from two reports involving Passiflora cincinnata and Eugenia uniflora against methicillin-resistant Staphylococcus aureus. In suspension, P. cincinnata produced a significant reduction in bacterial load at a nominal concentration of 100 µg/mL. In the animal model, the estimated reduction of 0.79 log10 relative to the vehicle did not demonstrate an advantage of photoactivation over the fraction in the dark. The E. uniflora coating produced reported reductions of approximately 50% at 8 h and 70% at 24 h relative to the initial count, without precise quantification of the additional benefit of light. In the contextual stratum, comprising 60 reports, preparations containing curcuminoids, chlorophyll derivatives, and different formulations showed activity in suspension and in some biofilm models. Experimental heterogeneity and insufficient precision precluded meta-analysis. Conclusions: The findings support the experimental potential of these preparations and guide the investigation of photoactive antimicrobial strategies, distinguishing the contribution of materials of Brazilian provenance from the contextual evidence. Although they do not establish clinical efficacy, the results identify preparations of interest and priorities in standardization, traceability, dosimetry, and safety for their pharmaceutical development.
Keywords:
antimicrobial photodynamic therapy
; plant-derived photosensitizers
; natural products
; antimicrobial resistance
; biofilms
; formulations
; botanical traceability
Copyright: This open access article is published under a Creative Commons CC BY 4.0 license, which permit the free download, distribution, and reuse, provided that the author and preprint are cited in any reuse.